Glucose Health Inc (GLUC) 0.1200 $GLUC Glucose Health(R)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Glucose Health Inc (GLUC) 0.1200 $GLUC

Glucose Health(R) - New Product for Pre & Type-2 Diabetes Now Available at Walmart
BusinessWire - Mon Jun 20, 6:45AM CDT
Glucose Health, Inc. (OTC: GLUC) today announced its innovative, non-prescription dietary supplement, formulated for persons with pre and Type-2 diabetes, Glucose Health(R) Daily Blood Sugar Maintenance, is now available in the "Diabetes Supplies" section at Walmart pharmacies nationwide, as well as online at walmart.com.
WMT: 71.62 (-0.73)

TriVita Launches Reformulated Glucose Health for Greater Blood Sugar Support
PRWeb - Tue Sep 15, 5:00AM CDT
In today's health-conscious world, it seems that everyone is looking for ways to optimize their health, starting with nutrition. TriVita, a North American nutraceutical firm based in Scottsdale, AZ, has launched the reformulation of their popular Amazon Herb supplement, Glucose Health. This proprietary blend of botanicals sourced from the Amazon Rainforest supports healthy blood sugar levels.

Glucose Health® Sales Update
PR Newswire - Mon Jun 29, 7:15AM CDT
Glucose Health, Inc. (OTCQB: GLUC) ("Company" is pleased to provide the following interim sales update:

Glucose Health(R) - Type-2 Diabetes Category Disruptor
BusinessWire - Wed Jun 03, 7:15AM CDT
Glucose Health, Inc. ("GLUC" or the "Company" today announced the uploading of a new quarterly letter to shareholders which, among items relating to the achievement of various corporate milestones, highlights the disruptive characteristics of the Company's namesake product, Glucose Health(R) Natural Blood Sugar Maintenance:

Glucose Health(TM)- New OTC Product For Type-2 Diabetes Health And Wellness
PR Newswire - Wed May 27, 7:15AM CDT
Healthcare professionals now have a new OTC (over- the-counter) product designed for the 2 in 5 Americans the Centers for Disease Control and Prevention (CDC) now estimates will develop Type-2 diabetes1 in their lifetime - Glucose Health(TM) Natural Blood Sugar Maintenance.

Glucose Health, Inc. Announces New Natural Product for Type-2 Diabetes Market
BusinessWire - Thu May 21, 7:15AM CDT
Glucose Health, Inc. (OTCQB: GLUC) (the "Company" today announced completion of the first production run of Glucose Health(TM) Natural Blood Sugar Maintenance - an innovative new product targeting the Type-2 Diabetes consumer market segment.

Glucose Health, Inc. Appoints Respected Nutrition Scientist As Advisor
PR Newswire - Thu Jan 29, 7:00AM CST
Glucose Health, Inc. (OTC: GLUC) ("Company" today announced the appointment of Chandrasekhar Mallangi, Ph.D., as an advisor to the Company, through the signing of an Agreement with CMS Consulting LLC, of which Dr. Mallangi is a principal.

Glucose Health, Inc. Announces Initial Filing With US Patent & Trademark Office
GlobeNewswire - Tue Jan 27, 10:08AM CST
Glucose Health, Inc. (OTC:GLUC) ("Company" today announced the filing of its initial application for trademark protection related to its Glucose Health line of dietary products, with the United States Trademark and Patent Office www.uspto.gov (USPTO). If the Company's application is successful and a trademark is awarded by the USPTO, a legal presumption of the Company's ownership nationwide of Glucose Health, and the exclusive right to use a trademark on or in connection with all Glucose Health branded products, as set forth in the registration, will exist.

New Dietary Product For Type 2 Diabetics Developed By Former Nestle Scientist
ACCESSWIRE - Mon Jan 26, 5:40PM CST
Bentonville, AR / ACCESSWIRE / January 26, 2015 / The Supply Side, a column read by national retail chain buyers, recently profiled Glucose Health, Inc., a manufacturer of a new non-prescription dietary product for Type 2 diabetics developed by a former Nestle food scientist.

Glucose Health, Inc. Completes Implementation of FDA Good Manufacturing Practices
GlobeNewswire - Wed Jan 07, 8:00AM CST
Glucose Health, Inc. ("GLUC" or the "Company" today announced it has completed implementation of Food and Drug Administration (FDA) Current Good Manufacturing Practices (CGMP). The Dietary Supplement (DS) CGMP rule in 21 CFR part 111 of the FDA's regulations requires companies which manufacture, package, label, or hold a dietary supplement to establish and follow current good manufacturing practice to ensure the quality of the dietary supplement and to ensure that the dietary supplement is packaged and labeled as specified in the master manufacturing record.

Glucose Health, Inc. To Upgrade To OTCQB® Venture Market
PR Newswire - Tue Dec 16, 7:15AM CST
Glucose Health, Inc. ("GLUC" or the "Company" today announced a series of corporate measures.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 5

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 14

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 5

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading

Top 5 Most Recently Viewed Articles

Red Pine Unveils Exciting Gold Discoveries at Wawa Project

Updated Category News Views 177

Red Pine Exploration's Impressive Drilling Results Red Pine Exploration Inc. (TSXV: RPX, OTCQB: RDEXF) is thrilled to announce outstanding results from its ongoing drilling program at the Wawa Gold Project. This Canadian gold exploration company has executed a comprehensive drilling initiative, totaling 2,793 meters across three drill holes, aiming to unlock the full...

Continue Reading
Silver's Backwardation: What It Means for Investors Today

Updated Category News Views 447

Understanding Silver's Current Market Dynamics Recently, silver's futures market revealed a significant shift, entering a state of backwardation not seen for four decades. This phenomenon indicates that the short-term contract price is considerably higher than longer-term futures, reflecting a dramatic demand for immediate physical silver. The difference of $2.88...

Continue Reading
PGIM High Yield Funds Announce Monthly Distributions

Updated Category News Views 508

PGIM Funds Unveil Distribution Plans for Shareholders NEWARK, N.J.--PGIM High Yield Bond Fund, Inc. (NYSE: ISD), PGIM Global High Yield Fund, Inc. (NYSE: GHY), and PGIM Short Duration High Yield Opportunities Fund (NYSE: SDHY) have announced their monthly distributions for December 2024, January, and February 2025. This initiative signifies their commitment to delivering...

Continue Reading
Investors Urged to Act as Altimmune Faces Legal Challenges

Updated Category News Views 156

Important Legal Investigations Concerning Altimmune, Inc. Faruqi & Faruqi, LLP is currently investigating potential claims on behalf of investors who may have suffered financial losses related to Altimmune, Inc. (NASDAQ: ALT). Investors who acquired securities of Altimmune should pay close attention to this matter, as there are critical developments that could affect...

Continue Reading
Conejo Valley Unified Faces Lawsuits Over Assault Inaction

Updated Category News Views 6

Legal Scrutiny Hits Conejo Valley Unified In what feels like a never-ending cycle of educational mishaps, Conejo Valley Unified School District and its Westlake High School find themselves under the harsh spotlight of the legal system. Two lawsuits filed in Ventura County Superior Court are laying bare some serious accusations against them. Former students, using the...

Continue Reading